Un centro de destino para la inmunoterapia en el norte de Texas

When it comes to immunotherapy for cancer, few hospitals offer what we do—all in one convenient location. Baylor Scott y White Charles A. Sammons Cancer Center - Dallas represents one of the largest cancer treatment centers in Texas and offers comprehensive immunotherapy care in one place.

Our dedicated cancer hospital, outpatient cancer center, cancer urgent care, and onsite overnight accommodations free-of-charge at the American Cancer Society’s Hope Lodge—along with numerous support services—provide a single destination to care for you as a whole person.

We continue to research and advance numerous immunotherapies every day. This means you have access to clinical trials you won’t find elsewhere—and even more hope to destroy cancer.

Terapia con células T CAR

New tumor-infiltrating lymphocytes (TIL) cellular therapy treatment

Baylor University Medical Center is one of the first in the nation to offer a new tumor-infiltrating lymphocytes (TIL) cellular therapy treatment for patients with metastatic melanoma. This novel therapy is the first and only FDA-approved cellular treatment for a solid tumor—specifically metastatic melanoma—and offers hope for patients with advanced melanoma.

Learn more about this breakthrough therapy

Combate el cáncer con tus propias células inmunitarias

El tratamiento del cáncer generalmente ha incluido tres enfoques principales: quimioterapia, radiación y cirugía. Ahora, la inmunoterapia le brinda una cuarta herramienta para vencer al cáncer.

Through cellular therapies in Dallas, we take your own immune cells, reprogram and multiply them in our lab, and infuse them back into your blood as new cancer-attacking cells. Other therapies use specific proteins or drugs to boost your immune system and help it fight cancer better.

Pioneering research and treatment in immunotherapies in Dallas, Baylor University Medical Center is one of the first North Texas providers to offer adult commercial use of chimeric antigen receptor T-cell therapy, or CAR-T, to treat patients with large B-cell lymphoma and acute lymphoblastic leukemia. We are also one of the first in the nation to offer FDA-approved tumor-infiltrating lymphocytes (TIL) cellular therapy for patients with metastatic melanoma.

Dependiendo de su cáncer, algunas inmunoterapias incluyen:

Trasplante de sangre y médula

A Blood and Marrow Transplant uses stem cells from bone marrow. Following chemotherapy, radiation therapy or both, the stem cells are infused into a person's bloodstream, where they begin to produce healthy stem cells and bone marrow.

Blood Marrow Transplant Program

Biorrepositorio de inmunooncología de Texas (TIOB)

El Biorepositorio de Inmuno-Oncología de Texas (TIOB) es un centro de investigación que recopila, cataloga y almacena muestras de material biológico, como orina, sangre, heces, tejidos, células, ADN, ARN y proteínas, en un esfuerzo por mejorar nuestra comprensión de cáncer.

Más información sobre TIOB

Edificio de investigación Lieberman

The Zelig H. Lieberman Research Building in Dallas houses the Baylor Institute for Immunology Research, where scientists and lab assistants work to advance knowledge of disease and its treatment.

Slide 1 of 4